Aberrant expression of miR-133a in endothelial cells inhibits angiogenesis by reducing pro-angiogenic but increasing anti-angiogenic gene expression
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Aberrant expression of miR-133a in endothelial cells inhibits angiogenesis by reducing pro-angiogenic but increasing anti-angiogenic gene expression ; volume:12 ; number:1 ; day:30 ; month:8 ; year:2022 ; pages:1-15 ; date:12.2022
Scientific reports ; 12, Heft 1 (30.8.2022), 1-15, 12.2022
- Creator
-
Ahmed, Suhail
Kurusamy, Sathishkumar
David, Ezra Leander Santhosh
Khan, Kinza
Kalyanakrishnan, Krithika
Ian-Gobo, Miebaka
Kola, Teja Manidhar
Wilkinson, Robert N.
Kannappan, Vinodh
Wang, Weiguang
Gómez, Manuel J.
Redondo, Juan Miguel
Cotton, James
Armesilla, Angel L.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-19172-x
- URN
-
urn:nbn:de:101:1-2022111721073251442778
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ahmed, Suhail
- Kurusamy, Sathishkumar
- David, Ezra Leander Santhosh
- Khan, Kinza
- Kalyanakrishnan, Krithika
- Ian-Gobo, Miebaka
- Kola, Teja Manidhar
- Wilkinson, Robert N.
- Kannappan, Vinodh
- Wang, Weiguang
- Gómez, Manuel J.
- Redondo, Juan Miguel
- Cotton, James
- Armesilla, Angel L.
- SpringerLink (Online service)
Other Objects (12)
Anti-angiogenic therapies in brain metastases
Anti-angiogenic alternatives to VEGF blockade
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Angiogenic and molecular diversity determine hepatic melanoma metastasis and response to anti-angiogenic treatment
Characterization of anti-angiogenic therapy response in glioblastoma
Anti-angiogenic therapies for advanced esophago-gastric cancer
Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy
MiR-106b exhibits an anti-angiogenic function by inhibiting STAT3 expression in endothelial cells
Comparison of anti-angiogenic properties of pristine carbon nanoparticles
Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
Anti-angiogenic effect of high doses of ascorbic acid
Anti-angiogenic therapies in brain metastases
Anti-angiogenic alternatives to VEGF blockade
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Angiogenic and molecular diversity determine hepatic melanoma metastasis and response to anti-angiogenic treatment
Characterization of anti-angiogenic therapy response in glioblastoma
Anti-angiogenic therapies for advanced esophago-gastric cancer
Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy
MiR-106b exhibits an anti-angiogenic function by inhibiting STAT3 expression in endothelial cells
Comparison of anti-angiogenic properties of pristine carbon nanoparticles
Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
Anti-angiogenic effect of high doses of ascorbic acid
Anti-angiogenic therapies in brain metastases
Anti-angiogenic alternatives to VEGF blockade
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Angiogenic and molecular diversity determine hepatic melanoma metastasis and response to anti-angiogenic treatment
Characterization of anti-angiogenic therapy response in glioblastoma
Anti-angiogenic therapies for advanced esophago-gastric cancer
Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy
MiR-106b exhibits an anti-angiogenic function by inhibiting STAT3 expression in endothelial cells
Comparison of anti-angiogenic properties of pristine carbon nanoparticles
Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma